Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome

Table 3 Chemotherapy treatment cycle in which invasive aspergillosis was first diagnosed

Chemotherapy treatment cycle	Number of patients that underwent chemotherapy treatment cycle, n	Cases of IA not recovered by the final chemotherapy cycle, n (%)	All IA cases, n (%)
Total	795	131 (16)	171 (22)
Cycle I	795	46 (6)	83 (10)
Cycle II	577	84 (15)	87 (15)
GO cycle I	114	0 (0)	0 (0)
GO cycle II	92	1 (1)	1 (1)
GO cycle III	65	0 (0)	0 (0)

Cycle I and II remission induction chemotherapy cycle I and II, GO cycle I, II and III gemtuzumab ozogacimin, post remission chemotherapy cycle I, II and III, IA invasive aspergillosis
Of note: Post-remission, 49 patients received reduced intensity allogeneic-stem cell transplantation (SCT) consolidation therapy. There were no data available about infections, or IA in particular, that occurred during or after SCT

ISSN: 1471-2334